SEI INVESTMENTS CO - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,122 filers reported holding NOVARTIS A G in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.

Quarter-by-quarter ownership
SEI INVESTMENTS CO ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$61,759,483
-3.7%
606,317
-4.6%
0.11%
-0.9%
Q2 2023$64,132,137
+6.2%
635,548
-3.1%
0.11%0.0%
Q1 2023$60,360,122
+5.7%
656,087
+4.2%
0.11%
-11.8%
Q4 2022$57,131,794
+25.2%
629,758
+4.9%
0.13%
+24.5%
Q3 2022$45,623,000
-16.4%
600,234
-6.9%
0.10%
-13.6%
Q2 2022$54,570,000
-7.2%
644,878
-3.8%
0.12%0.0%
Q1 2022$58,777,000
+1.5%
670,395
+1.2%
0.12%
+8.3%
Q4 2021$57,898,000
-19.6%
662,351
-24.7%
0.11%
-27.8%
Q3 2021$71,978,000
-6.7%
880,067
+4.1%
0.15%
-11.7%
Q2 2021$77,111,000
+9.7%
845,792
+4.6%
0.17%
-3.4%
Q1 2021$70,311,000
-5.5%
808,391
+2.6%
0.18%
-7.8%
Q4 2020$74,390,000
+7.6%
787,719
-1.0%
0.19%
-4.0%
Q3 2020$69,167,000
-7.1%
795,337
-6.7%
0.20%
-13.4%
Q2 2020$74,459,000
-21.4%
852,840
-25.8%
0.23%
-33.6%
Q1 2020$94,704,000
-21.5%
1,148,954
-9.8%
0.35%
-3.3%
Q4 2019$120,624,000
+14.8%
1,273,150
+5.2%
0.36%
+33.8%
Q3 2019$105,036,000
-6.9%
1,209,748
-2.2%
0.27%
-27.1%
Q2 2019$112,826,000
-7.9%
1,236,841
-2.9%
0.37%
-10.4%
Q1 2019$122,568,000
+9.3%
1,274,041
-2.3%
0.41%
+3.3%
Q4 2018$112,106,000
+1.9%
1,303,707
+2.2%
0.40%0.0%
Q3 2018$110,017,000
+0.8%
1,276,225
-11.7%
0.40%
+7.5%
Q2 2018$109,186,000
-2.9%
1,445,393
+3.9%
0.37%
-13.9%
Q1 2018$112,492,000
+18.6%
1,391,372
+23.1%
0.43%
+31.0%
Q4 2017$94,884,000
-0.3%
1,130,096
+1.9%
0.33%
-2.7%
Q3 2017$95,206,000
-23.5%
1,108,981
-25.6%
0.34%
-31.9%
Q2 2017$124,493,000
+50.2%
1,491,474
+33.7%
0.50%
+36.6%
Q1 2017$82,865,000
+10.6%
1,115,726
+8.5%
0.36%0.0%
Q4 2016$74,896,000
+1.4%
1,028,227
+10.0%
0.36%
-3.2%
Q3 2016$73,828,000
+43.1%
934,984
+49.6%
0.38%
+21.4%
Q2 2016$51,585,000
+13.4%
625,188
-0.5%
0.31%
+9.2%
Q1 2016$45,503,000
-9.2%
628,149
+7.8%
0.28%
-7.2%
Q4 2015$50,120,000
+72.6%
582,527
+84.4%
0.30%
+14.2%
Q3 2015$29,039,000
-1.7%
315,920
+5.2%
0.27%0.0%
Q2 2015$29,533,000
+0.9%
300,318
+1.1%
0.27%
+5.1%
Q1 2015$29,275,000
+7.4%
296,910
+1.0%
0.25%
+5.4%
Q4 2014$27,246,000294,0770.24%
Other shareholders
NOVARTIS A G shareholders Q1 2022
NameSharesValueWeighting ↓
GODSEY & GIBB, INC 184,900$15,121,0006.74%
Martin Investment Management, LLC 289,924$23,710,0005.98%
Camber Capital Management LP 2,000,000$163,560,0005.04%
MANAGED ASSET PORTFOLIOS, LLC 381,778$31,222,0004.76%
PROFESSIONAL ADVISORY SERVICES INC 267,779$21,899,0003.22%
SCHARF INVESTMENTS, LLC 1,244,711$101,794,0003.21%
GARLAND CAPITAL MANAGEMENT INC 50,755$4,151,0002.97%
First Fiduciary Investment Counsel, Inc. 167,378$13,688,0002.67%
WILKINS INVESTMENT COUNSEL INC 130,590$10,680,0002.61%
Lowell Blake & Associates Inc. 66,309$5,423,0002.52%
View complete list of NOVARTIS A G shareholders